Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 18:35:50 10/12/2024 GMT 		5-day change 1st Jan Change
4.695 USD -2.59% Intraday chart for Vanda Pharmaceuticals Inc. -4.68% +10.90%
11-06 Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q3 Revenue $47.7M MT
11-06 Vanda Pharmaceuticals Inc., Q3 2024 Earnings Call, Nov 06, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors
17/03/23
 CI
Insider Sell: Vanda Pharmaceuticals
07/12/22
 MT
H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc
25/04/22
 CI
Insider Sell: Vanda Pharmaceuticals
02/12/21
 MT
Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer
08/10/21
 CI
Insider Sell: Vanda Pharmaceuticals
17/09/21
 MT
Insider Sell: Vanda Pharmaceuticals
13/09/21
 MT
Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares
27/07/21
 MT
Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director
22/04/20
 CI
Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020
03/03/20
 CI
Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020
20/02/20
 CI
Vanda Pharmaceuticals Inc. Announces Board Changes
19/02/20
 CI
Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020
21/01/20
 CI
Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer
06/11/19
 CI
Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors
28/10/19
 CI
Vanda Pharmaceuticals Announces Management Appointments
21/08/19
 CI
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors
24/04/19
 CI
Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary
13/08/18
 CI
Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors
25/04/18
 CI
Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018
23/04/18
 CI
Paolo Baroldi Notifies His Resignation as Chief Medical Officer of Vanda Pharmaceuticals Inc., Effective March 22, 2017
13/03/17
 CI
Vanda Pharmaceuticals, Inc. Announces Howard H. Pien Not Stand to Re-Elect as Director
25/03/16
 CI
Vanda Pharmaceuticals Inc. Announces Executive Changes
21/12/15
 CI
Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals Inc
18/12/15
 CI
Vanda Pharmaceuticals, Inc. Appoints Richard Gulino as Senior Vice President, General Counsel and Secretary
14/09/15
 CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.
  5. Insiders
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition